Diagnostics

Date: Apr-2016 | Id: MACRC-0057 | Geographical Scope: United States

United States Breast Cancer Screening Market is expected to reach more than US$ 5.8 Billion by 2022.

Date: Apr-2016 | Id: MACRC-0050 | Geographical Scope: United States

United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023.

Date: Apr-2016 | Id: MACRC-0036 | Geographical Scope: Global

The global NIPT test market accounted for US$ XX Million in 2015 and is expected to reach US$ XX Million in 2016 and US$ XX Million by 2021, growing at a CAGR of XX% during the forecast period.

Date: Mar-2016 | Id: MACRC-0028 | Geographical Scope: China

The in–vitro Diagnostics(IVD) market in China has been growing rapidly in the past few years and is expected to grow steadily in the next few years, with major growth potential in segments such as infectious disease testing, chronic disease test...

Date: Mar-2016 | Id: MACRC-0026 | Geographical Scope: Global

Molecular Diagnostics has emerged as one of the largest and fastest growing segment in the IVD industry. It is the most dynamic and transformative areas of Diagnostics, leading to advances in research and treatment that are revolutionizing healt...

Date: Mar-2016 | Id: MACRC-0024 | Geographical Scope: Global

Point of care (POC) technologies are rapidly becoming part of the revolution of the healthcare landscape. With evolving high–tech innovations in healthcare, including smartphone apps, biosensors, lab–on–a chip, and wearable devices—all of which ...

Date: Apr-2016 | Id: MACRC-0044 | Geographical Scope: Global

The Potential Non-Invasive Prenatal Testing(NIPT) Market is expected to reach more than USD 4 Billion across the 15 major markets(15MM) by the year end of 2021.